Therapeutic approaches to Type 2 diabetes mellitus

Expert Opinion on Therapeutic Patents

Volumn 9, Issue 9, 1999, Pages 1223-1236

  Rose, M L ^a   Paulik, M A ^a   Lenhard, J M ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Diabetes; Obesity; Peroxisome proliferator activated receptor (PPAR ); Retinoid X receptor (RXR); Uncoupling protein (UCP); 3 adrenoceptor ( 3 AR)

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; ANTIDIABETIC AGENT; BETA 3 ADRENERGIC RECEPTOR; BEXAROTENE; GEMFIBROZIL; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR; ROSIGLITAZONE; SULFONYLUREA; THIAZOLIDINE DERIVATIVE; TRANSCRIPTION FACTOR; TROGLITAZONE; UNCOUPLING PROTEIN;

ADIPOCYTE; CELL DIFFERENTIATION; DEATH; DYSLIPIDEMIA; GENE EXPRESSION; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; LIVER TOXICITY; METABOLIC RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATENT; REVIEW; STROKE; THERMOGENESIS; WEIGHT GAIN;

EID: 0032825455     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.9.9.1223     Document Type: Review

References (151)